0

Anagrelide Related Compound A

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP85325128
CAS85325-12-8
Structure
Molecular Weight277.15 (free base basis)
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size25MG
1

[Anagrelide--new Antiplatelet Drug]

T Robak, J Treliński, A Hołub

Acta Haematol Pol. 1994;25(4):309-15.

PMID: 7847031

1

Anagrelide Metabolite Induces Thrombocytopenia in Mice by Inhibiting Megakaryocyte Maturation Without Inducing Platelet Aggregation

W J Lane, K Hattori, S Dias, E I Peerschke, M A Moore, D L Blanset, P C Lang, M Petrone, S Rafii

Exp Hematol. 2001 Dec;29(12):1417-24.

PMID: 11750100

1

PDE3A Inhibitor Anagrelide Activates Death Signaling Pathway Genes and Synergizes With Cell Death-Inducing Cytokines to Selectively Inhibit Cancer Cell Growth

Ran An, Jueyu Liu, Jing He, Fei Wang, Qing Zhang, Qiang Yu

Am J Cancer Res. 2019 Sep 1;9(9):1905-1921.

PMID: 31598394

1

Studies of Platelet Volume, Chemistry and Function in Patients With Essential Thrombocythaemia Treated With Anagrelide

S Bellucci, C Legrand, B Boval, L Drouet, J Caen

Br J Haematol. 1999 Mar;104(4):886-92.

PMID: 10192455

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode